Molecular Therapeutics: is One Promiscuous Drug Against Multiple Targets Better Than Combinations of Molecule-specific Drugs?
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Pazopanib: a novel multitargeted tyrosine kinase inhibitor.
Sonpavde G, Hutson T Curr Oncol Rep. 2007; 9(2):115-9.
PMID: 17288876 DOI: 10.1007/s11912-007-0007-2.
Barnett S, Defeo-Jones D, Fu S, Hancock P, Haskell K, Jones R Biochem J. 2004; 385(Pt 2):399-408.
PMID: 15456405 PMC: 1134710. DOI: 10.1042/BJ20041140.